The future of drug therapy and the effects on patient care
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Presentation
- By: SASEEN, Joseph (University of Colorado, Clinical Pharmacy and Family Medicine, Denver, United States of America)
Cardiometabolic (hypertension, dyslipidemia, diabetes) and rheumatologic (rheumatoid arthritis) diseases cause significant morbidity and mortality. Pharmacotherapy options for these diseases have exploded over the past decade. Many new drug classes have been developed to treat these conditions, and this trend will continue over the next decade... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.